STK33 Antikörper (serine/threonine Kinase 33) (Cy5)

Details for Product anti-STK33 Antibody No. ABIN1704600
Antigen
  • 4921505G21Rik
  • AW061264
  • serine/threonine kinase 33
  • STK33
  • Stk33
Reaktivität
Human, Maus, Ratte (Rattus)
114
28
20
Wirt
Kaninchen
99
15
Klonalität
Polyklonal
Konjugat
Dieser STK33 Antikörper ist konjugiert mit Cy5
6
6
5
4
4
4
2
2
2
2
2
1
1
1
1
1
1
1
1
1
Applikation
Immunofluorescence (Paraffin-embedded Sections) (IF (p))
84
55
44
21
16
12
8
7
3
1
1
Optionen
Immunogen KLH conjugated synthetic peptide derived from human STK33
Isotyp IgG
Reinigung Purified by Protein A.
Plasmids, Primers & others Plasmide, Primers & weitere STK33 products on genomics-online (e.g. as negative or positive controls)
Antigen
Andere Bezeichnung Stk33 (STK33 Antibody Abstract)
Hintergrund

The phosphorylation and dephosphorylation of proteins on serine and threonine residues is an essential means of regulating a broad range of cellular functions in eukaryotes, including cell division, homeostasis and apoptosis. A group of proteins that are intimately involved in this process are the serine/threonine (Ser/Thr) protein kinases. STK33 (serine/threonine kinase 33) is a 514 amino acid protein that belongs to the CaMK (calcium/calmodulin dependent kinase) subfamily of structurally related serine/threonine kinases. Widely expressed at low levels with predominant expression in testis, lung, retina and fetal organs such as brain, heart and spinal cord, STK33 contains one protein kinase domain and functions as a Ser/Thr protein kinase with a possible role in spermatogenesis. The gene encoding STK33 lies within a region on chromosome 11 that has been associated with a variety of defects, including Long QT syndrome, T-cell leukemia, Beckwith-Wiedemann syndrome, Usher syndrome 1C and various other malignancies.

Synonyms: Hypothetical protein FLJ35932, Serine threonine kinase 33, Serine/threonine kinase 33, Serine/threonine protein kinase 33, Serine/threonine-protein kinase 33, STK 33, Stk33, STK33_HUMAN.

Gen-ID 65975
Applikations-hinweise IF(IHC-P) 1:50-200
Beschränkungen Nur für Forschungszwecke einsetzbar
Format Liquid
Konzentration 1 μg/μL
Buffer Aqueous buffered solution containing 1 % BSA, 50 % glycerol and 0.09 % sodium azide.
Konservierungs-mittel Sodium azide
Vorsichtsmaßnahmen This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
Lagerung 4 °C
Informationen zur Lagerung Store at 4°C
Haltbarkeit 12 months
Haben Sie etwas anderes gesucht?